Skip to Main Content

Author Details

Himanshu Nagar
New York-Presbyterian Hospital, Weill Cornell Medical Center
2005
43
12
PMIDPaper TitleJournal TitlePublished Year
36334976Pulse Sequence Dependence of a Simple and Interpretable Deep Learning Method for Detection of Clinically Significant Prostate Cancer Using Multiparametric MRI.Acad Radiol2023
37608258Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER).BMC Cancer2023
37221397Complex implementation factors demonstrated when evaluating cost-effectiveness and monitoring racial disparities associated with [<sup>18</sup>F]DCFPyL PET/CT in prostate cancer men.Sci Rep2023
37245342The role of AI in prostate MRI quality and interpretation: Opportunities and challenges.Eur J Radiol2023
37236832Impact of Magnetic Resonance Imaging Targeting on Pathologic Upgrading and Downgrading at Prostatectomy: A Systematic Review and Meta-analysis.Eur Urol Oncol2023
37333345Use of focal radiotherapy boost for prostate cancer and perceived barriers toward its implementation: a survey.medRxiv2023
36776309MRI-LINAC: A transformative technology in radiation oncology.Front Oncol2023
36870853Transcriptomic Heterogeneity in High-risk Prostate Cancer and Implications for Extraprostatic Disease at Presentation on Prostate-specific Membrane Antigen Positron Emission Tomography.Eur Urol Oncol2023
36840651Prostate cancer grade migration and facility-level treatment trends for grade group 1 disease.JNCI Cancer Spectr2023
3464915168Ga-PSMA-HBED-CC PET/MRI is superior to multiparametric magnetic resonance imaging in men with biochemical recurrent prostate cancer: A prospective single-institutional study.Transl Oncol2022
35348709Grade Migration of Prostate Cancer in the United States During the Last Decade.J Natl Cancer Inst2022
35701333Evolving Trends in the Management of Low-Risk Prostate Cancer.Clin Genitourin Cancer2022
35814856Trends in Androgen Deprivation Use in Men With Intermediate-Risk Prostate Cancer Who Underwent Radiation Therapy.Adv Radiat Oncol2022
36466748Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States - Understanding the transition to adaptive, ultra-hypofractionated treatments.Clin Transl Radiat Oncol2022
36132128Adaptive magnetic resonance image guided radiation for intact localized prostate cancer how to optimally test a rapidly emerging technology.Front Oncol2022
36093321Corrigendum re "Hypofractionated Postoperative Radiotherapy for Prostate Cancer: Is the Field Ready Yet?" [Eur Urol Open Sci 2020;22:9-16].Eur Urol Open Sci2022
35880831Response to Takahashi.J Natl Cancer Inst2022
35182206Natural history of lower urinary tract symptoms among men undergoing stereotactic body radiation therapy for prostate cancer with and without a Rectal Hydrogel Spacer.World J Urol2022
32658588Active Surveillance for Men with Intermediate Risk Prostate Cancer.J Urol2021
33914220Ductal Carcinoma in Situ in Young Women: Increasing Rates of Mastectomy and Variability in Endocrine Therapy Use.Ann Surg Oncol2021
34522795Time management: Improving the timing of post-prostatectomy radiotherapy, clinical trials, and knowledge translation.Clin Transl Radiat Oncol2021
34184390Deep learning-based synthetic CT generation for MR-only radiotherapy of prostate cancer patients with 0.35T MRI linear accelerator.J Appl Clin Med Phys2021
34348105Prostate SBRT Dose Escalation (9 Gy⿯ÿ⿯5, 13.3 Gy⿯ÿ⿯3, 24 Gy⿯ÿ⿯1): Are We Making Progress?Int J Radiat Oncol Biol Phys2021
34342134Quantifying the impact of SpaceOAR hydrogel on inter-fractional rectal and bladder dose during 0.35 T MR-guided prostate adaptive radiotherapy.J Appl Clin Med Phys2021
34091024Re: Early Results of Unilateral Prostatic Artery Embolization as a Focal Therapy in Patients with Prostate Cancer under Active Surveillance: Cancer Prostate Embolization, a Pilot Study.J Vasc Interv Radiol2021
32341524Cancer and COVID-19 - potentially deleterious effects of delaying radiotherapy.Nat Rev Clin Oncol2020
34337473Hypofractionated Postoperative Radiotherapy for Prostate Cancer: Is the Field Ready Yet?Eur Urol Open Sci2020
32022878Trends in the Use of Stereotactic Body Radiotherapy for Treatment of Prostate Cancer in the United States.JAMA Netw Open2020
32865572Trends in Diagnosis and Disparities in Initial Management of High-Risk Prostate Cancer in the US.JAMA Netw Open2020
32386737Challenging the Norm: What Level of Evidence Is Necessary to Adopt Postprostatectomy Hypofractionated Radiation Therapy?Int J Radiat Oncol Biol Phys2020
29031423The State of Surgical Axillary Management and Adjuvant Radiotherapy for Early-stage Invasive Breast Cancer in the Modern Era.Clin Breast Cancer2018
29530585Omission of Adjuvant Radiotherapy in the Elderly Breast Cancer Patient: Missed Opportunity?Clin Breast Cancer2018
29661221Practice patterns and outcomes for patients with node-negative hormone receptor-positive breast cancer and intermediate 21-gene Recurrence Scores.Breast Cancer Res2018
25333731Older Patients With Early-stage Breast Cancer: Adjuvant Radiation Therapy and Predictive Factors for Cancer-related Death.Am J Clin Oncol2017
27764032The Addition of Low-Dose Total Body Irradiation to Fludarabine and Melphalan Conditioning in Haplocord Transplantation for High-Risk Hematological Malignancies.Transplantation2017
27746190Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non-Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database.J Thorac Oncol2017
27028349Adjuvant Pelvic Radiation Therapy±Vaginal Brachytherapy in Patients With High-risk Stage I or Stage II Uterine Papillary Serous, Clear Cell, and High-grade Endometrioid Carcinoma.Am J Clin Oncol2016
25459070Disease-free survival according to the use of postmastectomy radiation therapy after neoadjuvant chemotherapy.Clin Breast Cancer2015
24486121Impact of oncotype DX recurrence score in the management of breast cancer cases.Clin Breast Cancer2014
24291379Is there a tradeoff in using modified high tangent field radiation for treating an undissected node-positive axilla?Clin Breast Cancer2014
24138915Administration of concurrent vaginal brachytherapy during chemotherapy for treatment of endometrial cancer.Int J Radiat Oncol Biol Phys2013
21885207Local-regional recurrence with and without radiation therapy after neoadjuvant chemotherapy and mastectomy for clinically staged T3N0 breast cancer.Int J Radiat Oncol Biol Phys2011
15586361Mast cell tryptase may modulate endothelial cell phenotype in healing myocardial infarcts.J Pathol2005
  • 1 - 43 of 43

Recommended Authors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Career Start Year 2017
Number of shared co-authors 9
University of Michigan ann arbor
Career Start Year 2016
Number of shared co-authors 17
University of California Los Angeles
Career Start Year 2015
Number of shared co-authors 15
Stanford University
Career Start Year 2014
Number of shared co-authors 10
University of Michigan ann arbor
Career Start Year 2013
Number of shared co-authors 13
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 10
Oregon Health and Science University
Career Start Year 2012
Number of shared co-authors 9
Johns Hopkins University School of Medicine
Career Start Year 2012
Number of shared co-authors 17
University of Miami Miller School of Medicine
Career Start Year 2010
Number of shared co-authors 12
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 9
Taussig Cancer Institute, Cleveland Clinic
Career Start Year 2006
Number of shared co-authors 15
University of Texas Southwestern Medical Center
Career Start Year 2004
Number of shared co-authors 10
University of Toronto, Princess Margaret Cancer Centre
Career Start Year 2004
Number of shared co-authors 16
University of California Los Angeles
Career Start Year 2003
Number of shared co-authors 14
Ghent University, GZA Ziekenhuizen
Career Start Year 2002
Number of shared co-authors 15
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 4
Abramson Cancer Center, University of Pennsylvania
Career Start Year 2001
Number of shared co-authors 18
University of California Los Angeles
Career Start Year 2000
Number of shared co-authors 4
Cleveland Clinic
Career Start Year 2000
Number of shared co-authors 14
Thomas Jefferson University Hospital
Career Start Year 1999
Number of shared co-authors 17
Stanford University
Career Start Year 1999
Number of shared co-authors 10
William Beaumont School of Medicine
Career Start Year 1999
Number of shared co-authors 14
University of Chicago
Career Start Year 1997
Number of shared co-authors 9
University of California los angeles
Career Start Year 1996
Number of shared co-authors 21
Huntsman Cancer Institute, University of Utah
Career Start Year 1994
Number of shared co-authors 14
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 16
University of California los angeles
Career Start Year 1988
Number of shared co-authors 15
Duke University Medical Center
Career Start Year 1988
Number of shared co-authors 14
University of California San Francisco
Career Start Year 1983
Number of shared co-authors 18
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Career Start Year 1976
Number of shared co-authors 17

Collaborators

Weill Cornell Medical College
Co-authored papers 7
Weill Cornell Medical College
Co-authored papers 5
Weill Cornell Medical Center
Co-authored papers 5
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 4
University of California los angeles
Co-authored papers 3
Meyer Cancer Center, Weill Cornell Medicine-NewYork Presbyterian Hospital
Co-authored papers 3
Cornell University and Cornell Tech
Co-authored papers 2
Northwestern University Feinberg School of Medicine
Co-authored papers 2
Weill Cornell Medical College
Co-authored papers 2
Emory University School of Medicine
Co-authored papers 2
Weill Cornell Medical College
Co-authored papers 2
New York Presbyterian Hospital-Weill Cornell
Co-authored papers 2
New York-Presbyterian Hospital
Co-authored papers 2
David Geffen School of Medicine at university of california los angeles
Co-authored papers 1
University of California los angeles
Co-authored papers 1
David Geffen School of Medicine, University of California los angeles
Co-authored papers 1
Meyer Cancer Center, Englander Institute for Precision Medicine
Co-authored papers 1
University of Washington
Co-authored papers 1
Shiley Eye Institute, University of California
Co-authored papers 1
Sandra and Edward Meyer Cancer Center
Co-authored papers 1
NewYork-Presbyterian/Weill Cornell Medical Center.
Co-authored papers 1
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 1
University of California-Los Angeles
Co-authored papers 1
Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School
Co-authored papers 1
University Hospitals of Cleveland
Co-authored papers 1
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Co-authored papers 1
University of California los angeles
Co-authored papers 1
University of California-Los Angeles
Co-authored papers 1
Co-authored papers 1
university of california los angeles
Co-authored papers 1